Epidemiology of genital human papillomavirus infection

Epidemiologic Reviews

Volumn 10, Issue 1, 1988, Pages 122-163

  Koutsky, Laura A ^a   Galloway, Denise A ^b   Holmes, King K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONDYLOMA; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; REVIEW; RISK FACTOR; UTERINE CERVIX CANCER; WART VIRUS;

AMERICAS; CANCER; CERVICAL CANCER--ETIOLOGY; DEVELOPED COUNTRIES; DISEASES; EPIDEMIOLOGIC METHODS; INCIDENCE; INFECTIONS; LITERATURE REVIEW; MEASUREMENT; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; PREVALENCE; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

CONDYLOMATA ACUMINATA; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMAN; IMMUNITY, CELLULAR; MALE; PAPILLOMAVIRUS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR VIRUS INFECTIONS;

EID: 0023815225     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036020     Document Type: Article

References (279)

1. Taichman LB, LaPorta RF. The expression of papillomaviruses in epithelial cells. In: Salzman NP, Howley PM, eds. The Papovaviridae. Vol 2. New York: Plenum Press, 1987:109-39.
2. Danos O, Giri I, Thierry F, et al. Papillomavirus genomes: sequences and consequences. J Invest Dermatol 1984;83:7s-11s.
3. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971;47:1-13.
4. Rosenbaum J. The plague of lust. Being a history of venereal disease in classical antiquity, and including: detailed investigations into the cult of Venus and phallic worship, brothels, etc. Translated from the Sixth (unabridged) German Edition, Paris: C Carrington, 1907.
5. Rowson KEK, Mahy BWJ. Human papova (wart) virus. Bacteriol Rev 1967;31:110-31.
6. Rous P, Beard JW. Carcinomatous changes in virus-induced papillomas of the skin of the rabbit. Proc Soc Exp Biol Med 1935;32:578-80.
7. Rous P, Kidd JG. The carcinogenic effect of papilloma virus on the tarred skin of rabbits. I. Description of the phenomenon. J Exp Med 1938;67:399-428.
8. Barrett TJ, Silbar JD, McGinley JP. Genital warts—a venereal disease. JAMA 1954;154:333-4.
9. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann NY Acad Sci 1956;63:1245-61.
10. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976;20:505-9.
11. Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol 1977;21:26-31.
12. Gissmann L, zur Hausen H. Human papilloma viruses: physical mapping and genetic heterogeneity. Proc Natl Acad Sci USA 1976;73:1310-13.
13. Gissmann L, Pfister H, zur Hausen H. Human papilloma viruses (HPV): characterization of four different isolates. Virology 1977;76:569-80.
14. Orth G, Favre M, Croissant O. Characterization of a new type of human papillomavirus that causes skin warts. J Virol 1977;24:108-20.
15. Gissmann L, zur Hausen H. Partial characterization of viral DNA from human genital warts (condylomata acuminata). Int J Cancer 1980;25:605-9.
16. Giri I, Danos O. Papillomavirus genomes: from sequence data to biological properties. Trends Genet 1986;2:227-32.
17. Law MF, Lowy DR, Dvoretzky I, et al. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci USA 1981;78:2727-31.
18. Melnick JL, Allison AC, Butel JS, et al. Papovaviridae. Intervirology 1974;3:106-20.
19. Broker TR. Structure and genetic expression of papillomaviruses. Obstet Gynecol Clin N Am 1987;14:329-48.
20. Jenson AB, Rosenthal JD, Olson C, et al. Immunologic relatedness of papillomaviruses from different species. JNCI 1980;64:495-8.
21. Lancaster WD, Olson C. Animal papillomaviruses. Microbiol Rev 1982;46:191-7.
22. Pfister H. Papillomaviruses: general description, taxonomy, and classification. In: Salzman NP, Howley PM, eds. The Papovaviridae. Vol 2. New York: Plenum Press, 1987:1-38.
23. Coggin JR, zur Hausen H. Workshop on papillomaviruses and cancer. Cancer Res 1979; 39:545-6.
24. de Villiers E-M, Gissmann L, zur Hausen H. Molecular cloning of viral DNA from human genital warts. J Virol 1981;40:932-5.
25. Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983;80:560-3.
26. Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-15.
27. Boshart M, Gissmann L, Ikenberg H, et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
28. Lorincz AT, Lancaster WD, Temple GF. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol 1986;58:225-9.
29. Beaudenon S, Kremsdorf D, Croissant O, et al. A novel type of human papillomavirus associated with genital neoplasias. Nature 1986;321:246-9.
30. Lӧrincz AT, Quinn AP, Lancaster WD, et al. A new type of papillomavirus associated with cancer of the uterine cervix. Virology 1987;159:187-90.
31. Lӧrincz AT, Quinn AP, Schmidt BJ, et al. Prevalence of six new types of HPV in anogenital lesions and normal tissues from the United States. Presented at the Sixth International Papillomavirus Workshop, June 14-18, 1987, Washington, DC, 1987:139.
32. Broker TR, Chow LT. Human papillomaviruses of the genital mucosa: electron microscopic analyses of DNA heteroduplexes formed with HPV types 6, 11, and 18. In: Botchan M, Grodzicker T, Sharp PA, eds. DNA tumor viruses: control of gene expression and replication. Cancer cells. Vol 4. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986:589-94.
33. Gissmann L, Diehl V, Schultz-Coulon H-J, et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 1982;44:393-400.
34. Dartmann K, Schwarz E, Gissmann L, et al. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 1986; 151:124-30.
35. Chow LT, Hirochika H, Nasseri M, et al. Human papillomavirus gene expression. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:55-62.
36. Chen EY, Howley PM, Levinson AD, et al. The primary structure and genetic organization of the bovine papillomavirus type 1 genome. Nature 1982;299:529-34.
37. Giri I, Danos O, Yaniv M. Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci USA 1985;82:1580-4.
38. Danos O, Katinka M, Yaniv M. Human papillomavirus la complete DNA sequence: a novel type of genome organization among Papovaviridae. EMBO J 1982;1:231-6.
39. Schwarz E, Dürst M, Demankowski C, et al. DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J 1983;2:2341-8.
40. Seedorf K, Krammer G, Dürst M, et al. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.
41. Howley PM, Schlegel R. Papillomavirus transformation. In: Salzman NP, Howley PM, eds. The Papovaviridae. Vol 2. New York: Plenum Press, 1987:41-66.
42. Kreider JW, Howett MK, Stoler MH, et al. Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11. Int J Cancer 1987;39:459-65.
43. White DO, Huebner RJ, Rowe WP, et al. Studies on the virus of rabbit papilloma. I. Methods of assay. Aust J Exp Biol Med Sci 1963;41:41-50.
44. Kirchner H. Immunobiology of human papillomavirus infection. Prog Med Virol 1986;33:1-41.
45. Schiller JT, Vass WC, Vousdan KH, et al. The E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J Virol 1986;57:1-6.
46. Yang YC, Okayama H, Howley PM. Bovine papillomavirus contains multiple transforming genes. Proc Natl Acad Sci USA 1985;82:1030-4.
47. Lusky M, Botchan MR. Genetic analysis of bovine papillomavirus type 1 transacting replication factors. J Virol 1985;53:955-65.
48. Lusky M, Botchan MR. A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state. J Virol 1986;60:729-42.
49. Roberts JM, Weintraub H. Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids. Cell 1986;46:741-52.
50. Spalholz BA, Yang YC, Howley PM. Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product. Cell 1985;42:183-91.
51. Lambert P, Spalholz BA, Howley PM. Evidence that bovine papillomavirus type 1 may encode a negative transcriptional regulatory factor. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:15-22.
52. Phelps WC, Howley PM. Transcriptional transactivation by the human papillomavirus type 16 E2 gene product. J Virol 1987;61:1630-8.
53. Hirochika H, Broker TR, Chow LT. Enhancers and trans-acting E2 transcriptional factors of papillomaviruses. J Virol 1987;61:2599-2606.
54. Doorbar J, Campbell D, Grand RJA, et al. Identification of the human papillomavirus la E4 gene products. EMBO J 1986;5:355.
55. Komly CA, Breitburd F, Croissant O, et al. The L2 open reading frame of human papillomavirus type la encodes a minor structural protein carrying type-specific antigens. J Virol 1986;60:13.
56. Glinski W, Obalek S, Jablonska S, et al. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica 1981;162:141-7.
57. Haftek M, Jablonska S, Orth G. Specific cell- mediated immunity in patients with epidermodysplasia verruciformis and plane warts. Dermatologica 1985;170:213-20.
58. Halpert R, Fruchter RG, Sedlis A, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251-8.
59. Rudlinger R, Smith IW, Bunney MH, et al. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115:681-92.
60. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin N Am 1987;14:537-58.
61. Schneider V, Kay S, Lee HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983;27:220-3.
62. Frazer IH, Crapper RM, Medley G, et al. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 1986; 2:657-60.
63. Kent C, Samuel M, Winkelstein W Jr. The role of anal/genital warts in HIV infection. (Letter). JAMA 1987;258:85-6.
64. Eron LJ, Franklin J, Tucker S, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-64.
65. 2 interferon. J Infect Dis 1986;154:331-4.
66. Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? (Letter). Lancet 1987;2:1277-8.
67. Spurrett B, Jones DS, Stewart G. Cervical dysplasia and HIV infection. (Letter). Lancet 1988;1:237-8.
68. Crocchiolo P, Lizioli A, Goisis F, et al. Cervical dysplasia and HIV infection. (Letter). Lancet 1988;1:238-9.
69. Byrne M, Taylor-Robinson D, Harris JRW. Cervical dysplasia and HIV infection. (Letter). Lancet 1988;1:239.
70. Beckmann AM, Myerson D, Daling JR, et al. Detection and localization of human papillomavirus DNA in human genital condylomas by in situ hybridization with biotinylated probes. J Med Virol 1985;16:265-73.
71. 35S-labeled and biotin-labeled probes in detection of human papillomavirus DNA sequences. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:329-36.
72. Shelly W, Juhlin L. Langerhans’ cells form a reticuloepithelial trap for external contact aller-gens. Nature 1976;261:46-7.
73. Boog CJP, Kast WM, Timmers M, et al. Abolition of specific immune response defect by immunization with dendritic cells. Nature 1985;318:59-62.
74. Tay SK, Jenkins D, Maddox P, et al. Subpopulations of Langerhan’s cells in cervical neoplasia. Br J Obstet Gynaecol 1987;94:10-15.
75. McArdle JP, Muller HK. Quantitative assessment of Langerhans’ cells in human cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol 1986;154:509-15.
76. Chardonnet Y, Viac J, Thivolet J. Langerhans cells in human warts. Br J Dermatol 1986; 115:669-75.
77. Morris HHB, Gatter KC, Sykes G, et al. Langerhans’ cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol 1983;90:412-20.
78. Caorsi I, Figueroa CD. Langerhans’ cell density in the normal exocervical epithelium and in the cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1986;93:993-8.
79. Carson LF, Twiggs LB, Fukushima M, et al. Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol 1986;155:784-9.
80. Tay SK, Jenkins D, Maddox P, et al. Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol 1987;94:16-21.
81. Väyrynen M, Syrjänen K, Mäntyjärvi R, et al. Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix. Genitourin Med 1985;61:190-6.
82. Cauda R, Tyring SK, Grossi CE, et al. Patients with condyloma acuminata exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity. J Clin Immunol 1987;7:304-11.
83. Lodi A, Betti R, Cattaneo M, et al. A comparative study on peripheral blood lymphocyte subpopulations in different kinds of warts. Acta Derm Venereol (Stockh) 1987;67:169-72.
84. Tagami H, Oguchi M, Ofuji S. Immunological aspects of wart regression with special reference to regression phenomenon of numerous flat warts. J Dermatol (Tokyo) 1983;10:1-12.
85. Evans CA, Gorman LR, Ito Y, et al. Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines. JNCI 1962;29:277-85.
86. Steinberg BM, Topp WC, Schneider PS, et al. Laryngeal papillomavirus infection during clinical remission. N Engl J Med 1983;308:1261-4.
87. Kienzier JL. Humoral immunity to human papillomaviruses. In: Beiseh R, ed. Textbook of human virology. Littleton, MA: PSG Inc, 1984.
88. Jarrett WFH. The natural history of bovine papillomavirus infections. Adv Virol Oncol 1985; 5:83-101.
89. Kreider JW. Studies on the mechanism responsible for the spontaneous regression of the Shope rabbit papilloma. Cancer Res 1963;23:1593-9.
90. Pilacinski WP, Glassman DL, Glassman KF, et al. Immunization against bovine papillomavirus infection. In: Evered D, Clark S, eds. Papillomaviruses. Chichester (Ciba Foundation Symposium 120). New York: Wiley, 1986:136-49.
91. Jenison S, Firzlaff A, Langenberg A, et al. Identification of immuno-reactive antigens of human papillomavirus type 6b using E. coli-expressed fusion proteins. J Virol 1988;62:2115-23.
92. Schneider A, Oltersdorf T, Schneider V, et al. Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections. Int J Cancer 1987;39:717-21.
93. Jenson AB, Kurman RJ, Lancaster WD. Tissue effects of and host response to human papillomavirus infection. Obstet Gynecol Clin N Am 1987;14:397-406.
94. Friedman JM, Fialkow PJ. Viral “tumorigenesis” in man: cell markers in condylomata acuminata. Int J Cancer 1976;17:57-61.
95. Murray RF, Hobbs J, Payne B. Possible clonal origin of common warts (Verruca vulgaris). Nature 1971;232:51-2.
96. Buscema J, Shah K, Rosenshein N, et al. Genetic investigation of the cellular origin of vulvovaginal condylomata acuminata. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:2457.
97. Durst M, Kleinheinz A, Hotz M, et al. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 1985;66:1515-22.
98. Reid R, Greenberg M, Jenson AB, et al. Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 1987;156:212-22.
99. Lӧrincz AT, Temple GF, Kurman RJ, et al. Oncogenic association of specific human papillomavirus types with cervical neoplasia. JNCI 1987;79:671-7.
100. Lancaster WD, Castellano C, Santos C, et al. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 1986;154:115-19.
101. Gariglio P, Ocadiz R, Sauceda R. Human papillomavirus DNA sequences and c-myc oncogene alterations in uterine cervix carcinoma. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:343-8.
102. Prakash SS, Reeves WC, Sisson GR, et al. Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma. Int J Cancer 1985;35:51-7.
103. McCance DJ, Kalache A, Ashdown K, et al. Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer 1986;37:55-9.
104. Ikenberg H, Schwӧrker D, Pfleiderer A. Lack of c-myc gene amplification in genital tumours with different HPV status. Lancet 1987;2:77.
105. Lehn H, Ernst T-M, Sauer G. Transcription of episomal papillomavirus DNA in human condy-lomata acuminata and Buschke-Lӧwenstein tumours. J Gen Virol 1984;65:2003-10.
106. de Villiers E-M, Schneider A, Gross G, et al. Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immun 1986;174:281-6.
107. McCance DJ, Campion MJ, Clarkson PK, et al. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynecol 1985;92:1101-5.
108. Meanwell CA, Cox MF, Blackledge G, et al. HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet 1987;1:703-7.
109. Scholl SM, Kingsley Piliers EM, Robinson RE, et al. Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East Anglia. Int J Cancer 1985;35:215-18.
110. MacNab JCM, Walkinshaw SA, Cordiner JW, et al. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med 1986;315:1052-8.
111. Millan DWM, Davis JA, Torbet TE, et al. DNA sequences of human papillomavirus types 11,16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J 1986;293:93-6.
112. Fuchs PG, Girardi F, Pfister H. Papillomavirus infections in cervical tumors of Austrian patients. In: Steinberg BM, Brandsma JL, Taich- man LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:297-300.
113. Pratili MA, Le Doussal V, Harvey P, et al. Recherche de papillomavirus humains dans des cellules épithéliales du col utérin: fréquence des types 16 et 18: résultats préliminaires d’une étude clinique, cytologique et virologique. J Gynecol Obstet Biol Reprod (Paris) 1986;15:45-50.
114. Battista C, Hillova J, Hill M, et al. Detection of human papillomavirus types 6, 11, 16 and 18 in genital warts and cervical neoplasia. Biomed Pharmacother 1986;40:421-2.
115. Di Luca D, Pilotti S, Stefanon B, et al. Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis. J Gen Virol 1986;67:583-9.
116. Choo K-B, Pan C-C, Liu M-S, et al. Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J Med Virol 1987;21:101-7.
117. Tsunokawa T, Takebe N, Nozawa S, et al. Presence of human papillomavirus type-16 and type- 18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer 1986;37:499-503.
118. Yoshikawa H, Matsukura T, Yamamoto E, et al. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas. Jpn J Cancer Res 1985;76:667-71.
119. Gissmann L, Schneider A. Human papilloma virus DNA in preneoplastic and neoplastic genital lesions. In: Peto R, zur Hausen H, eds. Viral etiology of cervical cancer. Banbury Report 21.Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986:217-24.
120. Kulski JK, Howard MJ, Pixley EC. DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women. Immunol Cell Biol 1987; 65:77-84.
121. Lorincz AT, Lancaster WD, Kurman RJ, et al. Characterization of human papillomavirus in cervical neoplasias and their detection in routine clinical screening. In: Peto R, zur Hausen H, eds. Viral etiology of cervical cancer. Banbury Report 21. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986:225-37.
122. Fuchs PG, Girardi F, Pfister H. Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri. Int J Cancer 1988;41:41-5.
123. Lorincz AT, Temple GF, Patterson JA, et al. Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 1986;68:508-12.
124. de Villiers E-M, Wagner D, Schneider A, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987;2:703-6.
125. Toon PG, Arrand JR, Wilson LP, et al. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J 1986;293:1261-4.
126. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987;40:198-201.
127. Fife KH, Rogers RE, Zwickl BW. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J Infect Dis 1987;156:904-11.
128. Walboomers JMM, Fokke HE, Polak M, et al. In situ localization of human papilloma virus type 16 DNA in a metastasis of an endocervical adenocarcinoma. Intervirology 1987;27:81-5.
129. Sutton GP, Stehman FB, Ehrlich CE, et al. Human papillomavirus deoxyribonucleic acid in lesions of the female genital tract: evidence for type 6/11 in squamous carcinoma of the vulva. Obstet Gynecol 1987;70:564-8.
130. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-14.
131. Yee C, Krishman-Hewlett I, Baker CC, et al. Presence and expression of human papilloma virus sequences in human cervical carcinoma cell lines. Am J Pathol 1985;119:361-6.
132. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986;83:4680-4.
133. Shimoda K, Lancaster WD. Integration of human papillomavirus DNA sequences in mild cervical dysplasia. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:349-57.
134. Seth P, Manjunath N, Kaur H, et al. Presence of human papillomavirus and herpes type 2 DNA in chronic cervicitis and invasive cancer of the cervix uteri in North India. Presented at the Sixth International Papillomavirus Workshop, June 14-18, 1987, Washington, DC, 1987:66.
135. Schneider-Maunoury S, Croissant O, Orth G. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 1987; 61:3295-8.
136. Durst M, Croce CM, Gissmann L, et al. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987;84:1070-4.
137. Takebe N, Tsunokawa Y, Nozawa S, et al. Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers. Biochem Biophys Res Commun 1987; 143:837-44.
138. Schneider-Gädicke A, Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986;5:2285-92.
139. Firzlaff JM, Hsia C-NL, Halbert CPHL, et al. Polyclonal antibodies to human papillomavirus type-6b and type-16 bacterially derived fusion proteins. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:105-13.
140. Li C-CH, Shah KV, Seth A, et al. Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol 1987;61:2684-90.
141. Shirasawa H, Tomita Y, Sekiya S, et al. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987; 68:583-91.
142. Popescu NC, DiPaolo JA, Amsbaugh SC. Integration of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 1987;44:58-62.
143. Riou GF, Barrois M, Dutronquay V, et al. Presence of papillomavirus DNA sequences, amplification of c-myc and c-Ha-ros oncogenes and enhanced expression of c-myc in carcinomas of the uterine cervix. In: Papillomaviruses: molecular and clinical aspects. New York: Alan R Liss, Inc, 1987:47-56.
144. Rando RF, Lancaster WD, Han P, et al. The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology 1987;155:545-56.
145. Boshart M, zur Hausen H. Human papillomaviruses in Buschke-Lӧwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 1986;58:963-6.
146. Yasumoto S, Burkhardt AL, Doniger J, et al. Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J Virol 1986;57:572-7.
147. Durst M, Dzarlieva-Pertrusevzka P, Boukamp P, et al. Molecular and cytologic analysis of immortalized human primary keratinocytes obtained after transfection with human papilloma virus type 16 DNA. Oncogene 1987;1:251-6.
148. Kaur P, McDougall JK. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol 1988; 62:1917-24.
149. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977; 21:379-90.
150. Gross G, Ikenberg H, Gissmann L, et al. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985;85:147-52.
151. Gross G, Ikenberg H, de Villiers E-M, et al. Bowenoid papulosis: a venereally transmissible disease as reservoir for HPV 16. In: Peto R, zur Hausen H, eds. Viral etiology of cervical cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986:149-65.
152. Obalek S, Jablonska S, Beaudenon S, et al. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol 1986;14:433-44.
153. Patterson JW, Kao GF, Graham JH, et al. Bowenoid papulosis: a clinicopathologic study with ultrastructural observations. Cancer 1986; 57:823-36.
154. Campion MJ. Clinical manifestations and natural history of genital human papillomavirus infection. Obstet Gynecol Clin N Am 1987;14:363-88.
155. Henderson BR, Thompson CH, Rose BR, et al. Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization. J Med Virol 1987;21:381-93.
156. Jablonska S, Kawashima M, Obakek S, et al. Human papillomavirus-related cutaneous benign lesions and skin malignancies. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:30917.
157. Gissmann L, Dürst M, Oltersdorf T, et al. Human papillomaviruses and cervical cancer. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:275-80.
158. Syijänen KJ. Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol 1987;65:21-39.
159. Lӧrincz AT. Detection of human papillomavirus infection by nucleic acid hybridization. Obstet Gynecol Clin N Am 1987;14:451-69.
160. Coppleson M. Colposcopic features of papillo- maviral infection and premalignancy in the female lower genital tract. Obstet Gynecol Clin N Am 1987;14:471-94.
161. Rosenberg SK, Greenberg MD, Reid R. Sexually transmitted papillomaviral infection in men. Obstet Gynecol Clin N Am 1987;14:495-512.
162. Gottardi G, Gritti P, Marzi MM, et al. Colposcopic findings in virgin and sexually active teen-agers. Obstet Gynecol 1984;63:613-15.
163. Fegerl HE, Ajre JE. Studies of cervical lesions in virgins: a combined cytological and colposcopic evaluation. Cancer Cytol 1970;10:39-41.
164. Kadish AS, Burk RD, Kress Y, et al. Human papillomaviruses of different types in precancerous lesions of the uterine cervix. Hum Pathol 1986;17:384-92.
165. Follen MM, Levine RU, Carillo E, et al. Colposcopic correlates of cervical papillomavirus infection. Am J Obstet Gynecol 1987;157:809-14.
166. Jenkins D, Tay SK, McCance DJ, et al. Histological and immunocytochemical study of cervical intraepithelial neoplasia (CIN) with associated HPV 6 and HPV16 infections. J Clin Pathol 1986;39:1177-80.
167. Schneider A, Meinhardt G, de Villiers E-M, et al. Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies. Diagn Cytopathol 1987; 3:250-5.
168. Horn PL, Lowell DM, LiVolsi VA, et al. Reproducibility of the cytologic diagnosis of human papillomavirus infection. Acta Cytol 1985; 29:692-4.
169. Gupta JW, Gupta PK, Shah KV, et al. Distribution of human papillomavirus antigen in cervicovaginal smears and cervical tissues. Int J Gynecol Pathol 1983;2:160-70.
170. Gupta J, Pilotti S, Rilke F, et al. Association of human papillomavirus type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol 1987;127:206- 15.
171. Syrjänen K, Mäntyjärvi R, Väyrynen M, et al. Assessing the biological potential of human papillomavirus infections in cervical carcinogenesis. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:281-8.
172. Parker BJ, Cossart YE, Thompson CH, et al. The clinical management and laboratory assessment of anal warts. Med J Aust 1987;147:59-63.
173. Firzlaff JA, Kiviat NB, Beckmann AM, et al. Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the LI and L2 open reading frames. Virology 1988;164:467-77.
174. Wagner D, Ikenberg H, Boehm N, et al. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol 1984;64:767-72.
175. Schneider A, Kraus H, Schuhmann R, et al. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer 1985;35:443-8.
176. Gupta JW, Gupta PK, Rosenshein N, et al. Detection of human papillomavirus in cervical smears. Acta Cytol 1987;31:387-96.
177. Gergely L, Czegledy J, Hernady Z. Human papillomavirus frequency in normal cervical tissue (Letter). Lancet 1987;2:513.
178. Schneider A, Sawada E, Gissmann L, et al. Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol 1987;69:554-62.
179. Burk RD, Kadish AS, Calderin S, et al. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986;154:982-9.
180. Bergeron C, Ferenczy A, Shah KV, et al. Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol 1987; 69:736-42.
181. Palefsky J, Winkler B, Braga C, et al. The predictive value of pap smear, colposcopy, and cervical biopsy in determining human papillomavirus (HPV) type-16 positivity. In: Viruses and human cancer. New York: Alan R Liss, Inc, 1987:387-96.
182. Crum CP, Ikenberg H, Richart RM, et al. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med 1984;310:880-3.
183. Saiki RK, Sharf S, Faloona F, et al. Enzymatic amplification of beta globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1987;230:1350-4.
184. US Department of Health and Human Services. Sexually transmitted disease statistics, 1985. Issue no. 135. Public Health Service. CDC, Atlanta, GA, 1987.
185. Becker TM, Stone KM, Alexander ER. Genital human papillomavirus infection: a growing concern. Obstet Gynecol Clin N Am 1987;14:389-96.
186. Sexually transmitted diseases: extract from the annual report of the Chief Medical Officer of the Department of Health and Social Security for the year 1983. Genitourin Med 1985;61:204-7.
187. Chuang T-Y, Perry HO, Kurland LT, et al. Condyloma acuminatum in Rochester, Minnesota, 1950-1978. (Parts I and II). Arch Dermatol 1984;120:469-83.
188. Aral SO, Holmes KK. Epidemiology of sexually transmitted diseases. In: Holmes KK, Mardh PH, Sparling PF, et al, eds. Sexually transmitted diseases. New York: McGraw Hill, 1984:126-41.
189. Veneral Disease Control Division, Bureau of State Services, CDC. Current trends: nonreported sexually transmissible diseases—United States. MMWR 1979;28:61-3.
190. Lacey CJN, Mulcahy FM, Sutton J. Koilocyte frequency and prevalence of cervical human papillomavirus infection. Lancet 1986;1:557-8.
191. Armstrong BK, Allen OV, Brennan BA, et al. Time trends in prevalence of cervical cytological abnormality in women attending a sexually transmitted diseases clinic and their relationship to trends in sexual activity and specific infections. Br J Cancer 1986;54:669-75.
192. Meisels A, Morin C. Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 1981;12:S111-S23.
193. Drake M, Mitchell H, Medley G. Human papillomavirus infection of the cervix in Victoria, 1982-1985. Med J Aust 1987;147:57-9.
194. Zaninetti P, Franceschi S, Baccolo M, et al. Characteristics of women under 20 with cervical intraepithelial neoplasia. Int J Epidemiol 1986;15:477-82.
195. Armstrong BK, Allen OV, Brennan BA, et al. Time trends in the prevalence of cervical cytologic abnormality in women attending a sexually transmitted disease clinic and their relationship to trends in sexual activity and specific infections. Br J Cancer 1986;54:669-75.
196. III dans deux séries de conisations et hystérectomies (1957-1968 et 1981-1983). Bull Cancer (Paris) 1985;72:290-7.
197. Kock KF, Johansen P. Prevalence of condylo- matous atypia and human papilloma virus antigen in cervical biopsies in 1972 and 1983. Acta Obstet Gynecol Scand 1987;66:111-15.
198. Byrne P, Woodman C, Meanwell C, et al. Koi- locytes and cervical human papillomavirus infection. Lancet 1986;1:205-6.
199. Mazur MT, Cloud GA. The koilocyte and cervical intraepithelial neoplasia: time-trend analysis of a recent decade. Am J Obstet Gynecol 1984; 150:354-8.
200. Bernstein SG, Voet RL, Guzick DS, et al. Prevalence of papillomavirus infection in colposcop- ically directed cervical biopsy specimens in 1972 and 1982. Am J Obstet Gynecol 1985;151:577-80.
201. Beral V, Booth M. Predictions of cervical cancer incidence and mortality in England and Wales. (Letter). Lancet 1986;2:495.
202. Cook GA, Draper GJ. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer 1984;50:367-75.
203. Armstrong B, Holman D. Increasing mortality from cancer of the cervix in young Australian women. Med J Aust 1981;1:460-2.
204. Green GH. Rising cervical cancer mortality in young New Zealand women. NZ Med J 1979;89:89-91.
205. Pettersson F, Bjorkholm E, Nslund I. Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980. Int J Epidemiol 1985;14:521-7.
206. Worth AJ. The Walton Report and its subsequent impact on cervical cancer screening programs in Canada. Obstet Gynecol 1984;63:135-9.
207. Biometry Branch, Division of Cancer Prevention and Control, National Cancer Institute. Cancer incidence and mortality in the United States. Seer Program, 1973-81. (NIH publication no. 851837) (US Department of Health and Human Services, PHS, NIH). Bethesda, MD: National Cancer Institute, 1984:53-158.
208. Boon ME, Deng Z, Baowen G, et al. Koilocyte frequency in positive cervical smears as indicator of sexual promiscuity (Letter). Lancet 1986; 1:205.
209. Grussendorf-Conen E-I, de Villiers E-M, Gissmann L. Human papillomavirus genomes in penile smears of healthy men. (Letter). Lancet 1986;1:1092.
210. Ostrow RS, Zachow KR, Niimura M, et al. Detection of papillomavirus DNA in human semen. Science 1986;231:731-5.
211. Del Mistro A, Braunstein JD, Halwer M, et al.Identification of human papillomavirus types in male urethral condylomata acuminata by in situ hybridization. Hum Pathol 1987;18:936-40.
212. US Bureau of the Census, Statistical Abstract of the United States: 1987. (107th ed). Washington, DC, 1986:14-18.
213. Vallejos H, Del Mistro A, Kleinhaus S, et al. Characterization of human papilloma virus types in condylomata acuminata in children by in situ hybridization. Lab Invest 1987;56:611-15.
214. Roman A, Fife K. Human papillomavirus DNA associated with foreskins of normal newborns. J Infect Dis 1986;153:855-61.
215. Tang C, Shermeta DW, Wood C. Congenital condylomata acuminata. Am J Obstet Gynecol 1978;131:912-13.
216. Stumpf PG. Increasing occurrence of condylomata acuminata in premenarchal children. Obstet Gynecol 1980;56:262-4.
217. De Jong AR, Weiss JC, Brent RL. Condylomata acuminata in children. Am J Dis Child 1982; 136:704-6.
218. Fleming KA, Venning V, Evans M. DNA typing of genital warts and diagnosis of sexual abuse of children. Lancet 1987;2:454.
219. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical histopathologic and molecular studies. Laryngoscope 1987;97:678-85.
220. Quick CA, Watts SL, Krzyzek RA, et al. Relationship between condylomata and laryngeal papillomata. Ann Otol Rhonol Laryngol 1980; 89:467-71.
221. Cook TA, Brunschwig JP, Butel JS, et al. Laryngeal papilloma: etiologie and therapeutic considerations. Ann Otol Rhinol Laryngol 1973;82:649-55.
222. Reeves WC, Caussy D, Brinton LA, et al. Case- control study of human papillomaviruses and cervical cancer in Latin America. Int J Cancer 1987;40:450-4.
223. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1:1037-40.
224. Campion MJ, Singer A, Clarkson PK, et al. Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata. Lancet 1985;1:943-6.
225. Barrasso R, De Brux J, Croissant O, et al. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987;317:916-23.
226. Maitland NJ, Cox MF, Lynas C, et al. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987;56:246-50.
227. de Villiers E-M, Neumann C, Weidauer H, et al. Infection of the oral mucosa with defined types of human papillomaviruses. Med Microbiol Immunol (Berl) 1986;174:287-94.
228. Syrjänen SM, Syijänen KJ, Lamberg MA, et al. Detection of human papillomavirus DNA in oral mucosal lesions using in situ DNA-hybridization applied on paraffin sections. Oral Surg 1986; 62:660-7.
229. Oriel JD. Anal warts and anal coitus. Br J Vener Dis 1971;47:373-6.
230. Lass JH, Grove AS, Papale JJ, et al. Detection of human papillomavirus DNA sequences in conjunctival papilloma. Am J Ophthalmol 1983; 96:670-4.
231. McDonnell PJ, McDonnell JM, Kessis T, et al. Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol 1987;18:1115-19.
232. Brandsma J, Abramson A, Sciubba J, et al. Papillomavirus infection of the nose. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells. Vol 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1987:301-8.
233. Syijänen K, Väyrynen M, Castrén O, et al. Sexual behavior of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984;60:243-8.
234. Daling JR, Sherman KJ, Weiss NS. Risk factors for condyloma acuminatum in women. Sex Transm Dis 1986;13:16-18.
235. Franceschi S, Doll R, Gallwey J, et al. Genital warts and cervical neoplasia: an epidemiological study. Br J Cancer 1983;48:621-8.
236. Woodruff JD, Peterson WF. Condylomata acuminata of the cervix. Am J Obstet Gynecol 1958;75:1354-62.
237. Singer A. The uterine cervix from adolescence to the menopause. Br J Obstet Gynecol 1975;82:81-9.
238. Brinton LA. Current epidemiologic studies— emerging hypotheses. In: Peto R, zur Hausen H, eds. Viral etiology of cervical cancer. Banbury Report 21. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986:17-28.
239. La Vecchia C, Franceschi S, Decarli A, et al. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986;58:935-41.
240. Rothman KJ, Boice JD Jr. Epidemiologic analysis with a programmable calculator. (NIH publication no. 79-1649). Washington, DC: US GPO, 1979.
241. Tomita Y, Kubota K, Kasai T, et al. Detection of human papillomavirus DNA in genital warts, cervical dysplasias and neoplasias. Intervirology 1986;25:151-7.
242. Wells M, Griffiths S, Lewis F, et al. Demonstrations of human papillomavirus types in paraffin processed tissue from human anogenital lesions by in-situ DNA hybridization. J Pathol 1987; 152:77-82.
243. Villa LL, Lopes A. Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int J Cancer 1986;37:853-5.
244. McCance DJ, Lowe D, Simmons P, et al. Human papilloma virus in condyloma acuminata of the anus. J Clin Pathol 1986;39:927.
245. Hill SA, Coghill SB. Human papillomavirus in squamous carcinoma of anus. Lancet 1986; 2:1333.
246. Sherman KJ, Daling JR, Chu J, et al. Multiple primary tumors in women with vulvar neoplasms: a case-control study. Br J Cancer 1988;57:423-7.
247. Schneider A, de Villiers E-M, Schneider V. Multifocal squamous neoplasia of the female genital tract: significance of human papillomavirus in-fection of the vagina after hysterectomy. Obstet Gynecol 1987;70:294-8.
248. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987;317:973-7.
249. Bornstein J, Kaufman RH, Adam E, et al. Human papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbestrol in utero. Obstet Gynecol 1987;70:75-80.
250. Barnes W, Delgado G, Kurman R, et al. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988; 29:267-73.
251. Orth G. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM, eds. The Papovaviri- dae. Vol 2. New York: Plenum Press, 1987:199-243.
252. Fischer RG, Syverton JT. The virus-induced papilloma-to-carcinoma sequence. IV. Carcinomas in domestic rabbits infected while in utero. Cancer Res 1951;11:737-40.
253. Beasley RD, Lin CC, Hwang LY, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
254. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978;24:40-69.
255. Russell JM, Blair V, Hunter RD. Cervical carcinoma: prognosis in younger patients. Br Med J 1987;295:300-3.
256. zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 1982;2:1370-2.
257. Fenoglio CM. Viruses in the pathogenesis of cervical neoplasia: an update. Hum Pathol 1982;13:785-7.
258. Schachter J, Hill EC, King EB, et al. Chlamydia trachomatis and cervical neoplasia. JAMA 1982;248:2134-8.
259. Furgyik S, Åstedt B. Gonorrheal infection followed by an increased frequency of cervical carcinoma. Acta Obstet Gynecol Scand 1980; 59:521-4.
260. Koutsky LA, Kiviat NC, Stevens CS, et al. Human papillomavirus (HPV), cervical intraepithelial neoplasia (CIN) and bacterial vaginosis (BV). Abstract no. 31. Twentieth Annual Meeting of the Society for Epidemiologic Research, June 1619, 1987, Amherst MA, 1987:31.
261. Guijon FB, Paraskevas M, Brunham R. The association of sexually transmitted diseases with cervical intraepithelial neoplasia: a case control study. Am J Obstet Gynecol 1985;151:185-90.
262. Waterhouse J, Muir C, Correa P, et al, eds. Cancer incidence in five continents. Vol III. Lyon: International Agency for Research on Cancer, 1976.
263. Coppleson M, Pixley E, Reid B, eds. Colposcopy: a scientific and practical approach to the cervix and vagina in health and disease. 2nd ed. Springfield, IL: Charles C Thomas Publishers, 1978.
264. Koss LG., Diagnostic cytology and its histopathologic bases. 3rd ed. Philadelphia: Lippincott, 1979
265. Brandsma JL, Steinberg BM, Abramson AL, et al. Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res 1986;46:2185-8.
266. Scheurlen W, Stremlau A, Gissmann L, et al. Rearranged HPV 16 molecules in an anal and in a laryngeal carcinoma. Int J Cancer 1986;38:671-6.
267. Syrjänen S, Syrjänen K, Mäntyjärvi R, et al. Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization. ORL J Otorhinolaryngol Relat Spec 1987;49:175-86.
268. Ostrow RS, Manias DA, Fong WJ, et al. A survey of human cancers for human papillomavirus DNA by filter hybridization. Cancer 1987; 59:429-34.
269. Syrjänen KJ, Syrjänen SM. Human papillomavirus DNA in bronchial squamous cell carcinomas. Lancet 1987;1:168-9.
270. Syrjänen KJ. Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix. Lung 1980;158:131-42.
271. Byrne JC, Tsao M-S, Fraser RS, et al. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1987;317:873-8.
272. de Villiers E-M, Weidauer H, Otto H, et al. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985;36:575-8.
273. Kaufman RH, Bornstein J, Gordon AN, et al. Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma. Gynecol Oncol 1987;27:340-9.
274. Ferenczy A, Mitao M, Nagai N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313:784-8.
275. de Brux J, Orth G, Croissant O, et al. Lésions condylomateuses du col utérin: évolution chez 2466 patientes. Bull Cancer (Paris) 1983;70:410-22.
276. Mitchell H, Drake M, Medley G. Prospective evaluation of risk of cervical cancer after cyto- logical evidence of human papillomavirus infection. Lancet 1986;1:573-5.
277. Campion MJ, McCance DJ, Cuzick J, et al. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-40.
278. Briggs RM, Paavonen J. Cervical intraepithelial neoplasia. In: Holmes KK, Mårdh P-H, Sparling PF, et al, eds. Sexually transmitted diseases. New York: McGraw Hill, 1984:589-615.
279. Kwikkel HJ, Quaak MJ, de With C. Predictive value of the abnormal Pap smear: a retrospective analysis of error rates. Eur J Obstet Reprod Biol 1986;21:101-12.